Literature DB >> 12853036

Testican-1 inhibits attachment of Neuro-2a cells.

Henry S Marr1, Cora Jean S Edgell.   

Abstract

Testican-1 is a highly conserved, multidomain, chondroitin sulfate proteoglycan that is most abundantly transcribed in the brain by neurons. This testican messenger RNA is not detected in normal quiescent astrocytes, but is up regulated when these cells are activated in response to injury such as cerebral stroke. Other chondroitin sulfate proteoglycans found in glial scars, including neurocan, have been shown to inhibit neural cell attachment and neurite extensions and may thus impede axonal regeneration. Here we report the expression and purification of a proteoglycan form of recombinant testican and its effects on neuron-derived cells in culture. We demonstrate that testican inhibits attachment of Neuro-2a cells and their ability to form neurite extensions. Both testican proteoglycan and the core glycoprotein that has been depleted of chondroitin sulfate inhibit cell attachment. Pre-treatment of the culture substratum with testican inhibits Neuro-2a attachment, but pre-treatment of the cells with testican does not inhibit their attachment. Testican, therefore, blocks attachment sites on cultureware and may also block attachment sites in the extracellular matrix of the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853036     DOI: 10.1016/s0945-053x(03)00036-2

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  15 in total

1.  Testican-1 promotes resistance against Pseudomonas aeruginosa-induced keratitis through regulation of MMP-2 expression and activation.

Authors:  Elizabeth A Berger; Sharon A McClellan; Ronald P Barrett; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-18       Impact factor: 4.799

Review 2.  Diverse biological functions of the SPARC family of proteins.

Authors:  Amy D Bradshaw
Journal:  Int J Biochem Cell Biol       Date:  2012-01-09       Impact factor: 5.085

3.  The Interferon-Inducible Proteoglycan Testican-2/SPOCK2 Functions as a Protective Barrier against Virus Infection of Lung Epithelial Cells.

Authors:  Narae Ahn; Woo-Jong Kim; Nari Kim; Han Wook Park; Seung-Woo Lee; Joo-Yeon Yoo
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

4.  Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.

Authors:  Cheng Yang; Regina Fischer-Kešo; Tanja Schlechter; Philipp Ströbel; Alexander Marx; Ilse Hofmann
Journal:  Tumour Biol       Date:  2015-07-04

5.  SPOCK3, a risk gene for adult ADHD and personality disorders.

Authors:  Heike Weber; Claus-Jürgen Scholz; Christian P Jacob; Julia Heupel; Sarah Kittel-Schneider; Angelika Erhardt; Susanne Hempel; Brigitte Schmidt; Tilman Kiel; Alexandra Gessner; Klaus-Peter Lesch; Andreas Reif
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-29       Impact factor: 5.270

Review 6.  Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.

Authors:  Kathryn D Rodgers; James D San Antonio; Olena Jacenko
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

7.  Phylogenetic analysis of the human thyroglobulin regions.

Authors:  Abdelaziz Belkadi; Caroline Jacques; Frédérique Savagner; Yves Malthièry
Journal:  Thyroid Res       Date:  2012-05-01

8.  Differential expression patterns of striate cortex-enriched genes among Old World, New World, and prosimian primates.

Authors:  Toru Takahata; Rammohan Shukla; Tetsuo Yamamori; Jon H Kaas
Journal:  Cereb Cortex       Date:  2011-11-07       Impact factor: 5.357

9.  Differential expression patterns of occ1-related genes in adult monkey visual cortex.

Authors:  Toru Takahata; Yusuke Komatsu; Akiya Watakabe; Tsutomu Hashikawa; Shiro Tochitani; Tetsuo Yamamori
Journal:  Cereb Cortex       Date:  2008-12-10       Impact factor: 5.357

10.  Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression.

Authors:  Christian J Gröger; Markus Grubinger; Thomas Waldhör; Klemens Vierlinger; Wolfgang Mikulits
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.